NCEL vs DARE
Comparison between NLS Pharmaceutics Ltd (NCEL, Company) and Dare Bioscience Inc (DARE, Company).
Both NCEL and DARE are from the Healthcare sector.
5-Year PerformanceDARE has outperformed NCEL, delivering a return of -41.7% compared to -68.2%
NCEL vs DARE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
NCEL vs DARE - Historical Returns
Returns include dividend reinvestment.
NCEL vs DARE - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | NCEL | DARE |
|---|---|---|
| 2026 | +60.83% | -36.41% |
| 2025 | -91.28% | -40.06% |
| 2024 | -91.03% | -20.95% |
| 2023 | -57.86% | -64.38% |
| 2022 | +8.40% | -60.29% |
| 2021 | -61.59% | +52.67% |
| 2020 | N/A | +63.41% |
| 2019 | N/A | +11.14% |
| 2018 | N/A | -68.56% |
| 2017 | N/A | -71.90% |
| 2016 | N/A | -76.70% |
| 2015 | N/A | -56.39% |
| 2014 | N/A | -9.20% |
NCEL vs DARE Drawdown Comparison
The maximum drawdown for NCEL was -99.92%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for DARE was -99.91%, occurring on Jul 29, 2026. This drawdown has not yet recovered.
The current NCEL drawdown is -99.86%. The current DARE drawdown is -99.90%.
| Rank | NCEL | DARE |
|---|---|---|
| #1 | -99.92% Mar 12, 2021 - Mar 30, 2026 | -99.91% Mar 19, 2015 - Jul 29, 2026 |
| #2 | -35.41% Feb 11, 2021 - Mar 12, 2021 | -52.54% Jun 19, 2014 - Jan 7, 2015 |
| #3 | -9.34% Jan 29, 2021 - Feb 3, 2021 | -27.52% Jan 23, 2015 - Mar 18, 2015 |
| #4 | -7.69% Feb 4, 2021 - Feb 11, 2021 | -23.52% Apr 22, 2014 - Jun 18, 2014 |
| #5 | N/A | -7.09% Apr 14, 2014 - Apr 22, 2014 |
| #6 | N/A | -5.25% Jan 12, 2015 - Jan 23, 2015 |
| #7 | N/A | -3.34% Jan 8, 2015 - Jan 12, 2015 |
Correlation
Correlation between NCEL and DARE is 0.84 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks